Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_assertion type Assertion NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_head.
- NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_assertion description "[Some genes have been found altered in prostate cancer, such as PTEN, TP53, AR, RNASEL (HPC1), ELAC2 (HPC2), CDKN2A and MSR1 and those can be natural targets for new strategies of treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_provenance.
- NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_assertion evidence source_evidence_literature NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_provenance.
- NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_assertion SIO_000772 16648113 NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_provenance.
- NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_assertion wasDerivedFrom befree-20150227 NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_provenance.
- NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_assertion wasGeneratedBy ECO_0000203 NP306057.RAg2AdZxS-k1-WDempnU-xkA8GHkD9PLUlSk956r4gI0Y130_provenance.